Clinical Significance of Cytomegalovirus Reactivation in Patients With Plasma Cell Dyscrasia Who Were Treated With Anti-CD38 Monoclonal Antibody: A Retrospective Analysis in a Single Institution

CONCLUSION: This study provides an overview of the clinical impact of CMV reactivation in patients with PCD treated with anti-CD38 mAb-containing regimens.PMID:38653670 | DOI:10.1016/j.clml.2024.03.012

Source: Clinical Lymphoma and Myeloma - April 23, 2024 Category: Cancer & Oncology Authors: Naohiro Matsunaga Tomotaka Suzuki Nozomi Nishitarumizu Yoko Nakanishi Aki Kondo Yukiyasu Kato Toru Ebina Yoshiaki Marumo Tomoyuki Nakamura Takahiro Nakashima Shiori Kinoshita Tomoko Narita Masaki Ri Shigeru Kusumoto Hirokazu Komatsu Shinsuke Iida Source Type: research